98%
921
2 minutes
20
Background: It is well-established that maintaining stable intraocular pressure (IOP) within the normal range during ophthalmic surgery is important. Esketamine is a commonly used drug in pediatric general anesthesia due to its good analgesic and sedative effects. However, its application in ophthalmic surgery is limited because it can increase IOP. The effect of esketamine combined with other common anesthetics on IOP has been underinvestigated. This study aimed to investigate the effect of different doses of esketamine combined with propofol and sufentanil on IOP during intravenous induction of general anesthesia for pediatric strabismus surgery.
Methods: A total of 181 children with strabismus undergoing unilateral eye surgery under general anesthesia were recruited. Intravenous induction included the use of sufentanil 0.1 µg/kg, propofol 3 mg/kg, and esketamine. Base on the dosage of esketamine, the patients were randomly allocated into three groups: esketamine low (EL) group with 0.25 mg/kg (n = 62), esketamine high (EH) group with 0.5 mg/kg (n = 60), and normal saline (NS) group (n = 59). Hemodynamic parameters, respiratory parameters, and IOP of the non-surgical eye were recorded and compared among the three groups at different time points: before induction (T), 1 min after induction but before laryngeal mask insertion (T), immediately after laryngeal mask insertion (T), and 2 min after laryngeal mask insertion (T).
Results: There were no significant differences in age, gender, body mass index (BMI), and respiratory parameters among the three groups at T. The IOP at T, T, and T was lower than that at T in all three groups. The EH group (12.6 ± 1.6 mmHg) had a significantly higher IOP than the EL group (12.0 ± 1.6 mmHg) and the NS group (11.6 ± 1.7 mmHg) at T. However, no difference was found between the EL and NS groups at any time point. Systolic blood pressure (SBP) and heart rate (HR) at T, T, and T were lower than at baseline, and SBP and HR were higher at T than at T. Additionally, the EH group had a significantly higher HR at T than the other two groups. There was no significant difference in diastolic blood pressure (DBP) among the three groups at any time point.
Conclusion: Propofol combined with sufentanil significantly decreased IOP during the induction of general anesthesia. Although a dose of 0.5 mg/kg esketamine elevated IOP compared to the low-dose and control groups after induction, the IOP remained lower than baseline. 0.25 mg/kg esketamine combined with propofol and sufentanil had little effect on IOP. Therefore, we advocate that a maximum dose of 0.5 mg/kg esketamine combined with propofol and sufentanil will not elevate IOP compared to baseline in pediatric strabismus surgery.
Trial Registration: The registration number is ChiCTR2200066586 at Chictr.org.cn. Registry on 09/12/2022.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10426143 | PMC |
http://dx.doi.org/10.1186/s12871-023-02238-2 | DOI Listing |
Am J Geriatr Psychiatry
August 2025
Mood Disorder and Psychopharmacology Unit (RS, JKT, CED, RSM), University Health Network, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronnto, Toronto, ON, Canada; Department of Pharmacology and Toxicology, University of Toronto, ON, Canada. Electronic address: roger.mcintyre@
Ketamine has emerged as a promising treatment for major depression, though its efficacy and safety remain incompletely characterized in older adults. This systematic review synthesizes current evidence for ketamine in geriatric depression. A search of PubMed, EMBASE, and PsycINFO was conducted.
View Article and Find Full Text PDFJ Perianesth Nurs
September 2025
Department of Anesthesiology, The Second Affiliated Hospital of Xiamen Medical College, Xiamen, Fujian, China. Electronic address:
Purpose: This study aimed to evaluate the effects of different doses of esketamine with etomidate on anesthesia and postoperative cognitive function of elderly patients undergoing painless tracheoscopy.
Design: This was a double-blind, randomized controlled trial.
Methods: In this study, 150 patients over 65 were divided into group A (low-dose: 0.
J Cancer Res Ther
September 2025
Department of Anesthesiology, Cardiovascular Institute, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Background: This study evaluated the efficacy and safety of esketamine plus dexmedetomidine for sedation and analgesia during computed tomography (CT)-guided lung tumor percutaneous microwave ablation (MWA).
Methods: Patients undergoing CT-guided percutaneous MWA of lung tumors were randomly divided into two groups: esketamine plus dexmedetomidine (Group E) and sufentanil plus dexmedetomidine (Group S). The patients' general information, mean arterial pressure (MAP), heart rate (HR), peripheral oxygen saturation, respiratory rate (RR), partial pressure of end-tidal carbon dioxide, bispectral index, and Ramsay sedation score were recorded before anesthesia administration (T0), after dexmedetomidine loading dose (T1), during percutaneous puncture (T2), during ablation (T3), at the end of surgery (T4), and during recovery of consciousness (T5).
J Affect Disord
September 2025
Department of Traditional Chinese Medicine, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Jiangxi, China. Electronic address:
Introduction: Dysfunction in amygdala networks has been implicated in major depressive disorder (MDD). Pharmacological treatments, such as esketamine and sertraline, are believed to exert their antidepressant effects by modulating amygdalar activity. This study aimed to investigate the relationship between changes in dynamic functional connectivity (dFC) within amygdala subregions and treatment outcomes, with a focus on identifying potential neuroimaging markers.
View Article and Find Full Text PDFFront Psychiatry
August 2025
Mood and Anxiety Disorder Unit, Psychiatric Specialties Service, Department of Psychiatry, Geneva University Hospital, Geneva, Switzerland.
Introduction: Intranasal Esketamine is an effective rapid-acting antidepressant currently used to treat treatment-resistant depression. Artificial intelligence is another emerging tool in medicine, but little is known about the effectiveness of combining these innovations in psychiatry.
Methods: This case report presents the outcome of a 37-year-old patient who received intranasal Esketamine treatment (84 mg) and utilized artificial intelligence (ChatGPT-4) to generate images and interpretations of his experiences with dissociation.